SCHEMBL20174732

SCHEMBL20174732

c1ccc(-c2nc(-c3cccc4c3C3(c5ccccc5-4)c4ccccc4-c4sc5ccccc5c43)nc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 2/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 2/20 0.31
LMNA P02545 2/20 0.31
RAB9A P51151 2/20 0.31
RECQL P46063 1/20 0.31
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174446 0.89 MAPT (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174536 0.88 KDM4E (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174455 0.86 KDM4E (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174462 0.86 KDM4E (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174460 0.86 L3MBTL1 (0.35) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL24905088 0.84 MAPT (0.47) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174521 0.84 S1PR1 (0.35) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174461 0.82 MAPT (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174503 0.82 CYP1A1 (0.40) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL22326533 0.82 MEN1 (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPT 811/4885SMN1; SMN2 3407/4885KDM4E 3633/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPT 811/4885SMN1; SMN2 3407/4885KDM4E 3633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.